ANDA 74288, held by Pharmobedient. Acebutolol Hydrochloride.
As of Nov 16, 2026, ANDA 74288 (Acebutolol Hydrochloride), held by Pharmobedient, was first approved by FDA on Apr 24, 1995, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 24, 1995 | Original application | Approved | None posted |
| Acebutolol HydrochlorideEQ 200MG BASE · capsule;oral | Acebutolol Hydrochloride | Discontinued |
| Acebutolol HydrochlorideEQ 400MG BASE · capsule;oral | Acebutolol Hydrochloride | Discontinued |
| Mar 28, 2014 | Supplement 10Manufacturing | Approved | None posted |
| Mar 26, 2014 | Supplement 9Labeling · Standard review | Approved | None posted |
| Nov 4, 1999 | Supplement 3Labeling | Approved | None posted |
| Jun 23, 1998 | Supplement 2Labeling | Approved | None posted |
| Feb 5, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Apr 24, 1995 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters